Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · SAMBHAAV

SAMBHAAV MED

Consumer DiscretionaryMedia₹109 cr market cap
₹5.46 ▼ -3.87% today As of 19 Nov 2026
52-week low ₹5.1052-week high ₹11.02

-48.5% from the 52-week high · +11.4% above the low

Sambhaav Media Ltd. is a holding company, which engages in the provision of media services. The company is headquartered in Ahmedabad, Gujarat. The firm is engaged in the business of publishing newspapers and magazines, audio-video media in the form of the public entertainment system and digital media by way of online portals, social media and varied advertising and communication. The firm's segments include Media and Allied Business and Technology and Allied Business. Its media products include Sambhaav Metro, which is an informative afternoon daily, Abhiyaan-weekly magazine for the family; Wise TV, which is a public entertainment system; VTV News, which is a Gujarati news channel; Top FM, which consists of about eight frequency modulation (FM) radio channels in Gujarat and five FM radio channels in Jammu and Kashmir, and VTV Gujarati, which is a digital portal. The firm has launched a Web portal for news, entertainment, gaming, and knowledge sharing. The firm also launched iOS and Android-based mobile applications.

The short version. SAMBHAAV MED reported revenue of ₹11 crore for Sep 2026, up 10.0% from a year earlier. Return on equity was 0.3% in Mar 2026. Promoter holding was 62.93% in Sep 2026, up 0.00 points over 8 quarters.

1 · The price

How has the stock traded?

SAMBHAAV MED trades 48.5% below its 52-week high and 11.4% above its 52-week low.

Change over period: —

1M-1.6%
3M-10.6%
6M-18.9%
1Y-38.5%

2 · The business

Is it growing?

Sales, year on year+10.0%

Sep 2026 revenue of ₹11 cr.

Net margin-2.2%

0.9 pts higher than a year earlier.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue111013111091111
Net profit0-2000001
Net margin %-2.2-21.13.12.8-3.1-1.8-0.34.5
EPS (₹)-0.01-0.110.020.02-0.02-0.010.00.03

Annual

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue4342404045424842
Net profit001-30-213
Net margin %0.51.01.5-6.40.0-3.91.16.1
EPS (₹)0.010.020.03-0.140.0-0.090.030.13

3 · The quality

How well does it turn capital into profit?

Return on equity was 0.3% in Mar 2026; debt to equity is 0.01.

Profitability · 4 years

Returns and margins

Mar 2026Mar 2025Mar 2024Mar 2023
Return on equity %0.30.50.7-3.1
Return on capital %2.31.83.82.4
EBITDA margin %14.816.420.718.6
Net margin %0.50.91.4-6.1

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR1.0%-0.3%
Profit CAGR——
Debt to equity0.01
Interest cover1.9x
Current ratio6.19

4 · The owners

Who holds it, and are they adding?

Promoter holding62.93%

Unchanged over 8 quarters.

Foreign institutions0.25%

Unchanged over 8 quarters.

Mutual fund schemes0

+0 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter62.9362.9362.9362.9362.9362.9362.9362.930.0
FII0.250.250.250.250.310.250.250.250.0
DII000000000
Public36.8236.8236.8236.8236.7536.8236.8236.820.0

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for SAMBHAAV MED are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about SAMBHAAV MED

What is the SAMBHAAV MED share price?

SAMBHAAV MED (SAMBHAAV) last closed at ₹5.46, down 3.87% on the day. Its 52-week range is ₹5.10 to ₹11.02.

What is the market cap of SAMBHAAV MED?

SAMBHAAV MED has a market capitalisation of about ₹109 crore.

How are SAMBHAAV MED's latest results?

SAMBHAAV MED reported revenue of ₹11 crore for Sep 2026, up 10.0% from a year earlier. Return on equity was 0.3% in Mar 2026. Promoter holding was 62.93% in Sep 2026, up 0.00 points over 8 quarters.

Who owns SAMBHAAV MED?

As of Sep 2026, shareholding was: Promoter 62.93%, FII 0.25%, Public 36.82%.

How many mutual funds hold SAMBHAAV MED?

0 mutual fund schemes held SAMBHAAV MED in October 2026. That compares with 0 the month before.

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.